Effects of Ranitidine and Cimetidine on Plasma Lipoproteins in Healthy Subjects
Authors:
- 1 February 1986
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 26 (2) , 97-99
Abstract
Serum lipoproteins were monitored in 24 healthy subjects receiving either ranitidine or cometidine for four weeks. Ranitidine produced a significant (P < .05) reduction in high-density lipoprotein (HDL)-cholesterol in both men and women. Cimetidine caused a nonsignificant increase in HDL-cholesterol and a reduction in LDL-cholesterol that was significant (P < .05) only in women. As these drugs had opposite effects on HDL-cholesterol levels, the mechanism of action is unlikely to be medicated by H2-receptor blockade.Keywords
This publication has 9 references indexed in Scilit:
- Effects of cimetidine and ranitidine on high density lipoprotein cholesterol concentrations.BMJ, 1985
- A long-term study of the effects of norethisterone on lipoprotein metabolism in menopausal womenClinica Chimica Acta, 1983
- CIMETIDINE AND HDL CHOLESTEROLThe Lancet, 1983
- New drugs. H2 receptor antagonists--cimetidine and ranitidine.BMJ, 1983
- Pharmacokinetics of the H2‐ receptor antagonist ranitidine in man.British Journal of Clinical Pharmacology, 1981
- A micro-method for the rapid ultracentrifugal separation of human plasma high density lipoprotein subfractions, HDL2 and HDL3Clinica Chimica Acta, 1981
- Cimetidine and ranitidine in duodenal ulcer.BMJ, 1980
- Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects.Gut, 1979
- PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASEThe Lancet, 1975